Cargando…

Spotlight on fevipiprant and its potential in the treatment of asthma: evidence to date

Asthma is a heterogeneous disease, which may be classified into phenotypes and endotypes based on clinical characteristics and molecular mechanisms. The best described endotype of severe asthma is type 2 (T2)-high asthma, characterized by release of inflammatory cytokines by T helper 2 (T(H)2) cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Christina C, Parulekar, Amit D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324611/
https://www.ncbi.nlm.nih.gov/pubmed/30662272
http://dx.doi.org/10.2147/JAA.S167973